Herceptin Market Expected to Grow from $4.29 Billion in 2024 to $6.33 Billion by 2034 at 4% CAGR
Market Overview The Herceptin market is a critical segment within the pharmaceutical industry, focused on trastuzumab, a monoclonal antibody widely used in treating HER2-positive breast and gastric …
